Godela M.Brosnahan et al. Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study American Journal of Kidney Diseases.
Publication Date
August 12, 2021
How Analyze was Used
“To ensure consistency, volumetric measurements of TKV were done on de-identified images by 1 reader (Dr. Wei Wang) who was blinded to study assignment, in one batch after study completion, using Analyze software (Analyze 11.0, Mayo Foundation, Rochester, MN).”
Keywords
Autosomal dominant polycystic kidney disease, Total kidney volume, Estimated glomerular filtration rate, Metformin, AMPK activator
Author Affiliation(s)
University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA